Summary:
Experience Moderate to Severe Ulcerative Colitis?
If so, you may qualify for a clinical research study of an investigational drug for ulcerative colitis at Global Medical Research.
Qualified Participants Must:
• Have moderate to severe ulcerative colitis (UC)
•
Be between the ages of 18 and 80
•
Have a diagnosis of UC for two or more months prior to joining the study
•
Not be satisfied with your response to one of the following types of treatment during the past five years:- Immunomodulators
- TNF-(alpha) antagonists
- Corticosteroids
*Other conditions may apply. You cannot participate if you have a history of Crohn's disease, indeterminate colitis, or the presence or history of fistula consistent with Crohn's disease.
Qualified Participants May Receive:
- Study-related drug at no cost
- Study-related medical exams at no cost
- Compensation for time and travel